Holly Mabillard

416 total citations
15 papers, 121 citations indexed

About

Holly Mabillard is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Holly Mabillard has authored 15 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Holly Mabillard's work include Renal and related cancers (5 papers), Genetic and Kidney Cyst Diseases (4 papers) and Diabetes Treatment and Management (4 papers). Holly Mabillard is often cited by papers focused on Renal and related cancers (5 papers), Genetic and Kidney Cyst Diseases (4 papers) and Diabetes Treatment and Management (4 papers). Holly Mabillard collaborates with scholars based in United Kingdom, United States and Germany. Holly Mabillard's co-authors include John A. Sayer, Eric Olinger, Shalabh Srivastava, Philip Haslam, Katrina Wood, Caroline Kempf, Shreya Raman, Sumaya Alkanderi, Helen Pearce and Friedhelm Hildebrandt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cell Science and Nephrology Dialysis Transplantation.

In The Last Decade

Holly Mabillard

12 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holly Mabillard United Kingdom	6	62	39	38	23	20	15	121
Takuma Takata Japan	7	56 0.9×	17 0.4×	61 1.6×	9 0.4×	8 0.4×	11	203
Luciana Guilhermino Pereira Brazil	6	70 1.1×	8 0.2×	24 0.6×	27 1.2×	24 1.2×	9	159
Marguerite Hureaux France	11	117 1.9×	47 1.2×	58 1.5×	28 1.2×	50 2.5×	24	213
Yuki Oba Japan	6	37 0.6×	31 0.8×	33 0.9×	15 0.7×	29 1.4×	60	144
Anja Schrewe Germany	6	82 1.3×	63 1.6×	29 0.8×	9 0.4×	41 2.0×	6	174
Ilhem Ben Charfeddine Tunisia	8	70 1.1×	59 1.5×	32 0.8×	23 1.0×	9 0.5×	13	178
Katie Sullivan Canada	8	56 0.9×	33 0.8×	42 1.1×	36 1.6×	12 0.6×	15	178
Ruth Armstrong United Kingdom	6	25 0.4×	27 0.7×	21 0.6×	7 0.3×	14 0.7×	16	108
Olga Beltcheva Bulgaria	8	166 2.7×	82 2.1×	177 4.7×	6 0.3×	14 0.7×	18	314
Giacomo Mengozzi Italy	8	59 1.0×	34 0.9×	47 1.2×	23 1.0×	7 0.3×	12	240

Countries citing papers authored by Holly Mabillard

Since Specialization

Citations

This map shows the geographic impact of Holly Mabillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Mabillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Mabillard more than expected).

Fields of papers citing papers by Holly Mabillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Mabillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Mabillard. The network helps show where Holly Mabillard may publish in the future.

Co-authorship network of co-authors of Holly Mabillard

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Mabillard. A scholar is included among the top collaborators of Holly Mabillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Mabillard. Holly Mabillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Olinger, Eric, et al.. (2025). Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy. Journal of Cell Science. 138(20).

Mabillard, Holly, et al.. (2025). GLP-1 receptor agonists—another promising therapy for Alport syndrome?. PubMed. 4(1). 5–5.

Mabillard, Holly, et al.. (2024). Explaining Alport syndrome—lessons from the adult nephrology clinic. PubMed. 3(1). 14–14. 4 indexed citations

Imtiaz, Faiqa, Amal Alhashem, Holly Mabillard, et al.. (2024). ANKS6 Variants Underlie Polycystic Kidneys in Prenatal and Neonatal Cases. Genes. 15(11). 1374–1374.

Geraghty, Robert, et al.. (2023). Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome. PubMed. 2(1). 9–9. 2 indexed citations

Pearce, Helen & Holly Mabillard. (2023). Finerenone and other future therapeutic options for Alport syndrome. SHILAP Revista de lepidopterología. 2(1). 18–18. 1 indexed citations

Mabillard, Holly, et al.. (2023). Genetic analysis and outcomes of Omani children with steroid‐resistant nephrotic syndrome. Molecular Genetics & Genomic Medicine. 11(9). e2201–e2201. 4 indexed citations

Mabillard, Holly, Eric Olinger, & John A. Sayer. (2022). UMOD and you! Explaining a rare disease diagnosis. PubMed. 1(1). 4–4. 1 indexed citations

Olinger, Eric, Yaşar Çalışkan, Holly Mabillard, et al.. (2022). Biallelic variants in TTC21B as a rare cause of early‐onset arterial hypertension and tubuloglomerular kidney disease. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 190(1). 109–120. 7 indexed citations

10.

Olinger, Eric, Yaşar Çalışkan, Holly Mabillard, et al.. (2022). 958 Biallelic variants in TTC21B as a rare cause of early-onset arterial hypertension and tubuloglomerular kidney disease. A97–A98. 1 indexed citations

11.

Mabillard, Holly, John A. Sayer, & Eric Olinger. (2021). Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease. Nephrology Dialysis Transplantation. 38(2). 271–282. 19 indexed citations

12.

Mabillard, Holly & John A. Sayer. (2020). SGLT2 inhibitors – a potential treatment for Alport syndrome. Clinical Science. 134(4). 379–388. 22 indexed citations

13.

Mabillard, Holly & John A. Sayer. (2019). The Molecular Genetics of Gordon Syndrome. Genes. 10(12). 986–986. 34 indexed citations

14.

Molinari, Elisa, Eva L. Decker, Holly Mabillard, et al.. (2018). Human urine-derived renal epithelial cells provide insights into kidney-specific alternate splicing variants. European Journal of Human Genetics. 26(12). 1791–1796. 18 indexed citations

15.

Mabillard, Holly, et al.. (2017). Large Retroperitoneal Haemorrhage Following Cyst Rupture in a Patient with Autosomal Dominant Polycystic Kidney Disease. Case Reports in Nephrology. 2017. 1–3. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact